Norethindrone Acetate

醋炔诺酮

Report date: 2023/01/13 20:00:32
NME

Base Information

Drug NameNorethindrone Acetate
Drug Alias NameNorethisterone Acetate醋酸炔诺酮炔诺酮醋酸酯MilligynonAygestin +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProgesterone receptor agonists
TargetsProgesterone receptor
Therapy Area/IndicationsContraceptionAmenorrheaUterine Hemorrhage +[5] 
Global Approved IndicationsAmenorrheaUterine HemorrhageEndometriosis
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved DateN/A
Country/TerritoryUnited StatesItalyMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDuramed IncUniversity Of MessinaAmerican Watson Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsContraceptionAmenorrheaUterine Hemorrhage +[5] 

Other Information

ATC CodeG03AC01G03DC02
Related LinksWikipediaDrugBankKEGG